Literature DB >> 26450535

Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer Disease in Patients with Cognitive Impairment.

Y Inoue1, M Nakajima2, H Uetani3, T Hirai3, M Ueda2, M Kitajima3, D Utsunomiya3, M Watanabe2, M Hashimoto4, M Ikeda4, Y Yamashita3, Y Ando2.   

Abstract

BACKGROUND AND
PURPOSE: Because the diagnostic significance of cortical superficial siderosis for Alzheimer disease and the association between cortical superficial siderosis and the topographic distribution of cerebral microbleeds have been unclear, we investigated the association between cortical superficial siderosis and clinicoradiologic characteristics of patients with cognitive impairment.
MATERIALS AND METHODS: We studied 347 patients (217 women, 130 men; mean age, 74 ± 9 years) who visited our memory clinic and underwent MR imaging (3T SWI). We analyzed the association between cortical superficial siderosis and the topographic distribution of cerebral microbleeds plus clinical characteristics including types of dementia. We used multivariate logistic regression analysis to determine the diagnostic significance of cortical superficial siderosis for Alzheimer disease.
RESULTS: Twelve patients (3.5%) manifested cortical superficial siderosis. They were older (P = .026) and had strictly lobar cerebral microbleeds significantly more often than did patients without cortical superficial siderosis (50.0% versus 19.4%, P = .02); the occurrence of strictly deep and mixed cerebral microbleeds, however, did not differ in the 2 groups. Alzheimer disease was diagnosed in 162 (46.7%) patients. Of these, 8 patients (4.9%) had cortical superficial siderosis. In the multivariate logistic regression analysis for the diagnosis of Alzheimer disease, lacunar infarcts were negatively and independently associated with Alzheimer disease (P = .007).
CONCLUSIONS: Although cortical superficial siderosis was associated with a strictly lobar cerebral microbleed location, it was not independently associated with Alzheimer disease in a memory clinic setting. Additional studies are required to investigate the temporal changes of these cerebral amyloid angiopathy-related MR imaging findings.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26450535      PMCID: PMC7959944          DOI: 10.3174/ajnr.A4496

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis.

Authors:  S Gao; H C Hendrie; K S Hall; S Hui
Journal:  Arch Gen Psychiatry       Date:  1998-09

3.  Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies.

Authors:  S Kumar; R P Goddeau; M H Selim; A Thomas; G Schlaug; A Alhazzani; D E Searls; L R Caplan
Journal:  Neurology       Date:  2010-03-16       Impact factor: 9.910

4.  Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study.

Authors:  Jacques De Reuck; Vincent Deramecourt; Charlotte Cordonnier; Didier Leys; Florence Pasquier; Claude-Alain Maurage
Journal:  J Neurol Sci       Date:  2010-10-20       Impact factor: 3.181

5.  A new rating scale for age-related white matter changes applicable to MRI and CT.

Authors:  L O Wahlund; F Barkhof; F Fazekas; L Bronge; M Augustin; M Sjögren; A Wallin; H Ader; D Leys; L Pantoni; F Pasquier; T Erkinjuntti; P Scheltens
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

6.  Cerebral amyloid angiopathy in dementia and old age.

Authors:  M M Esiri; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia.

Authors:  H Uetani; T Hirai; M Hashimoto; M Ikeda; M Kitajima; F Sakamoto; D Utsunomiya; S Oda; S Sugiyama; J Matsubara; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

9.  Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease.

Authors:  Howard H Feldman; Luis F Maia; Ian R A Mackenzie; Bruce B Forster; Jeff Martzke; Andrew Woolfenden
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

10.  Epidemiology of clinically diagnosed Alzheimer's disease.

Authors:  W A Rocca; L A Amaducci; B S Schoenberg
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

View more
  8 in total

1.  Superficial siderosis misdiagnosed as idiopathic bilateral neurosensorial deafness.

Authors:  H A González-Usigli; Teresa Perez-Torres; Michel Saenz-Farret; Paloma Rivero-Moragrega
Journal:  BMJ Case Rep       Date:  2018-07-11

2.  Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population.

Authors:  Sara Shams; Juha Martola; Andreas Charidimou; Lena Cavallin; Tobias Granberg; Mana Shams; Yngve Forslin; Peter Aspelin; Maria Kristoffersen-Wiberg; Lars-Olof Wahlund
Journal:  Neurology       Date:  2016-08-17       Impact factor: 9.910

3.  Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke.

Authors:  Satoshi Suda; Takashi Shimoyama; Shizuka Suzuki; Takahiro Ouchi; Masafumi Arakawa; Junya Aoki; Kentaro Suzuki; Yuki Sakamoto; Seiji Okubo; Yasuhiro Nishiyama; Chikako Nito; Masahiro Mishina; Kazumi Kimura
Journal:  J Neurol       Date:  2017-10-23       Impact factor: 4.849

Review 4.  The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.

Authors:  Gargi Banerjee; Roxana Carare; Charlotte Cordonnier; Steven M Greenberg; Julie A Schneider; Eric E Smith; Mark van Buchem; Jeroen van der Grond; Marcel M Verbeek; David J Werring
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-08-26       Impact factor: 10.154

Review 5.  Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy.

Authors:  Yasuteru Inoue; Yukio Ando; Yohei Misumi; Mitsuharu Ueda
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 6.  [Current findings on the coincidence of cerebral amyloid angiopathy and Alzheimer's disease].

Authors:  R Haußmann; P Homeyer; M Donix; J Linn
Journal:  Nervenarzt       Date:  2021-10-15       Impact factor: 1.297

7.  Superficial siderosis as a rare cause of visual and auditory pseudohallucinations: a case report.

Authors:  Tobias Braun; Maxime Viard; Tobias Struffert; Omar AlhajOmar; Mesut Yeniguen; Martin Juenemann
Journal:  J Med Case Rep       Date:  2021-07-10

8.  Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease.

Authors:  Chris J Carter
Journal:  J Alzheimers Dis Rep       Date:  2017-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.